Dabur India to launch slew of products to retain edge

Rajeev Jayaswal

New Delhi, Nov 4: Notwithstanding the economic slowdown and weak consumer sentiment, Dabur India Ltd has decided to launch a range of new products over the remaining five months of this fiscal, and plans to increase operational efficiency by revamping top-level corporate structure.

“The nationwide launch of six new products including Dabur Sat Isabgol and anti-cancer drug Vinelvine in the domestic market are on cards, a top-level source in Dabur told The Financial Express.

“Three new products in healthcare and personal care will be launched by the end of this fiscal,” he said. Dabur has five SBUs including family products, healthcare, ayurvedic speciality, pharmaceutical and exports. Dabur is planning to develop some of its brands like NatureCare as a separate umbrella brand for premium family and healthcare products.

Stating that Dabur will aggressively launch new products in the market to increase its topline, the official said: “At the same time, the company has streamlined its top-level management to increase operational efficiency to maximise shareholders’ value.”

The company has appointed its director (corporate affairs) PD Narang in the management committee.